Research Article

Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort

Figure 1

Clinical features of the 245 (62.3%) anti-dsDNA + (group 1), 52 (13.3%) anti-dsDNA ± (group 2), and 96 (24.4%) anti-dsDNA − (group 3) SLE patients. group 1 versus group 2 and group 1 versus group 3; group 3 versus group 1 and group 3 versus group 2.